Illumina, Inc.
ILMN
Clasificación en acciones
#618
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Precio por acción
$262.32
Última sincronización: 2026-10-16
Capitalización bursátil
$39.61B
Cambio (1 día)
-2.09%
Cambio (1 año)
174.80%
País
US
Comercio Illumina, Inc. (ILMN)
Categoría
Healthcare
Margen Operativo de Illumina, Inc. (ILMN)
Margen Operativo al October 2026 TTM: 20.97%
Según los informes financieros más recientes y el precio de las acciones de Illumina, Inc., el margen operativo actual (TTM) es 20.97%. Al final de 2024, el margen operativo era -19.05%.
Historial de Margen Operativo de Illumina, Inc. desde 2000 hasta 2026
Margen Operativo al final de cada año
| Año | Margen Operativo | Cambiar |
|---|---|---|
| 2026 (TTM) | 20.97% | 5.27% |
| 2025 | 19.92% | -204.57% |
| 2024 | -19.05% | -19.72% |
| 2023 | -23.73% | 772.43% |
| 2022 | -2.72% | -115.19% |
| 2021 | 17.91% | -35.58% |
| 2019 | 27.80% | 4.95% |
| 2018 | 26.49% | 20.30% |
| 2017 | 22.02% | -20.28% |
| 2016 | 27.62% | -0.11% |
| 2014 | 27.65% | 192.90% |
| 2013 | 9.44% | -46.00% |
| 2012 | 17.48% | -25.46% |
| 2011 | 23.45% | 24.40% |
| 2010 | 18.85% | 34.26% |
| 2008 | 14.04% | -117.10% |
| 2007 | -82.12% | -500.98% |
| 2006 | 20.48% | -287.89% |
| 2005 | -10.90% | -88.52% |
| 2003 | -94.96% | -77.22% |
| 2002 | -416.88% | -65.82% |
| 2001 | -1,219.59% | -31.29% |
| 2000 | -1,774.87% | 0.00% |
Margen Operativo de empresas similares o competidoras
| Empresa | Margen Operativo | Diferencia de Margen Operativo | País |
|---|---|---|---|
| 17.97% | -99.14% |
US
|
|
| 20.42% | -99.03% |
US
|
|
| -10.70% | -100.51% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.94% |
US
|
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.